Sarah L. Ondrejka

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma”.

Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma

Cancer Research(2020)10.1158/0008-5472.can-19-1077

N/A

0.546DataRank · unranked

37 citations

Huimin Liu, Chuanfeng Fang, Chen Li, Fjorela Xhyliu, Hayley Dysert +16 more

The Genetic Basis of Hepatosplenic T-cell Lymphoma

UNC Libraries(2020)10.17615/vdkf-4m21

N/A

0DataRank · unranked

0 citations

Wing C. Chan, Steven M. Horwitz, Eric D. Hsi, Anupama Reddy, Nicholas S. Davis +50 more

Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2

UNC Libraries(2020)10.17615/x41h-8903

N/A

0DataRank · unranked

0 citations

Randy D. Gascoyne, Brooke C. Palus, Sandeep S. Davé, Tiffany J. Tzeng, Jiayu Yu +31 more

Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303

Blood Advances(2023)10.1182/bloodadvances.2023010779

N/A

0DataRank · unranked

24 citations

Kilannin Krysiak, Cody A. Ramirez, Matthew Mosior, Marcus P. Watkins, Felicia Gomez +18 more

CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma

Leukemia(2023)10.1038/s41375-023-01997-8

N/A

0DataRank · unranked

14 citations

Liping Luo, Lingjun Zhang, Joel Chen, Frank P. DiFilippo, Charlie Androjna +7 more